However, triple-negative breast cancer (TNBC), constituting 15–20% of diagnosed breast cancers, carries a worse prognosis than other subtypes due to the absence of HER-2/neu and ER/PR receptors [2,3,4,5]. Here, ERBB2 is linked to triple-negative breast carcinoma.